Reach is excited to release our Strategic Plan 2019-2020 outlining our new mission and vision statements, together with our strategic priority areas and objectives looking ahead to 2020. The Strategic Plan unambiguously outlines our aim to be the global technical lead in rheumatic heart disease prevention and control.
Founded in 2013, Reach has evolved in response to a rapidly growing body of evidence, and a combination of local and global campaigning aimed at lifting the profile of rheumatic heart disease. Since our inception Reach has aimed to meet a global demand for technical advice, epidemiological and operational research, and support for people and organisations working to prevent and control rheumatic fever (RF) and rheumatic heart disease (RHD).
Following changes to the organisation structure of Reach in 2018 and strategic planning meetings with the board the strategic plan expands on Reach’s mission to promote the health of vulnerable populations through technical support to local, regional and global efforts to prevent and control rheumatic fever and rheumatic heart disease.
“Since 2017, Reach has focused on building strategic relationships at the regional and national level, advising and supporting decision-makers and programme implementers,” said Reach Executive Director Jeremiah Mwangi.
“While we are strengthening existing relationships, we also recognise the importance of embracing a wider range of organisations who have a role to play in RHD control efforts.”
“Reach’s proposed programme of activities is targeted towards addressing many of the outstanding needs in RHD prevention and control. Only through collaboration across sectors and regions can these ambitious goals be realised,” Mr Mwangi said.